SCHEMBL19082186

SCHEMBL19082186

c1ccc(-c2ccc(-c3c4ccccc4c(-c4cc5c6ccccc6sc5c5c4sc4cc6ccccc6cc45)c4ccccc34)c3ccccc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 1/20 0.38
TNKS2 Q9H2K2 1/20 0.38
MAPT P10636 3/20 0.35
PTPN1 P18031 1/20 0.33
F9 P00740 1/20 0.33
ALOX5 P09917 1/20 0.33
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ESR1 P03372 2/20 0.31
ESR2 Q92731 2/20 0.31
GPR3 P46089 1/20 0.31
ALDH1A1 P00352 2/20 0.31
HPGD P15428 2/20 0.31
CHEK1 O14757 1/20 0.31
WEE1 P30291 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
MPI P34949 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082332 0.92 TNKS (0.37) TNKSTNKS2MAPTPTPN1ALOX5
SCHEMBL17945225 0.90 TNKS (0.43) TNKSTNKS2MAPTPTPN1F9
SCHEMBL19082241 0.89 TNKS (0.39) TNKSTNKS2MAPTPTPN1F9
SCHEMBL19082113 0.88 ALOX5 (0.36) TNKSTNKS2MAPTPTPN1ALOX5
SCHEMBL19082133 0.85 ALOX5 (0.35) TNKSTNKS2MAPTPTPN1ALOX5
SCHEMBL19082246 0.85 ALOX5 (0.38) TNKSTNKS2MAPTPTPN1F9
SCHEMBL19082259 0.84 ALOX5 (0.38) TNKSTNKS2MAPTPTPN1F9
SCHEMBL19082166 0.84 ALOX5 (0.35) TNKSTNKS2MAPTPTPN1ALOX5
SCHEMBL19082346 0.83 TNKS (0.36) TNKSTNKS2MAPTPTPN1ALOX5
SCHEMBL19082189 0.82 CHEK1 (0.37) TNKSTNKS2MAPTPTPN1F9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 TNKS 2635/4885TNKS2 2644/4885MAPT 1294/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 TNKS 2635/4885TNKS2 2644/4885MAPT 1294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.